Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo sublingual tablet
DRUG
3 trials
Sponsors
Bispebjerg Hospital
, Melt Pharmaceuticals
, Tonix Pharmaceuticals, Inc.
Conditions
Allergic Asthma Due to Dermatophagoides Pteronyssinus
Cataract
Depression
Major Depressive Disorder (MDD)
Major Depressive Episode (MDE)
Phase 2
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Recruiting
NCT07621237
Tonix Pharmaceuticals, Inc.
Depression, Major Depressive Disorder (MDD), Major Depressive Episode (MDE)
Start: 2026-06-01
End: 2028-02-01
Target: 360
Updated: 2026-06-02
Phase 3
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Recruiting
NCT06383273
Melt Pharmaceuticals
Cataract
Start: 2024-05-01
End: 2025-01-31
Target: 528
Updated: 2024-08-02
Phase 4
The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma
Completed
NCT04100902
Bispebjerg Hospital
Allergic Asthma Due to Dermatophagoides Pteronyssinus
Start: 2020-01-20
End: 2022-02-27
Updated: 2022-05-10
Related Papers
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial.
2023-05-01
43 citations